Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome

MeSH terms

• Acute-Phase Reaction / drug therapy*
• Acute-Phase Reaction / etiology
• Acute-Phase Reaction / immunology
• Adalimumab
• Adult
• Antibodies, Monoclonal, Humanized / administration & dosage*
• Antirheumatic Agents / administration & dosage
• Cytoskeletal Proteins / genetics
• Female
• Genetic Markers / genetics
• Humans
• Injections, Subcutaneous
• Magnetic Resonance Imaging
• Mevalonate Kinase Deficiency* / diagnosis
• Mevalonate Kinase Deficiency* / drug therapy
• Mevalonate Kinase Deficiency* / immunology
• Mevalonate Kinase Deficiency* / physiopathology
• Mutation
• Phosphotransferases (Alcohol Group Acceptor) / genetics*
• Pyrin
• Remission Induction
• Sacroiliitis / drug therapy*
• Sacroiliitis / etiology
• Severity of Illness Index
• Time
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors